Instead, administering forskolin (5 mg/kg/day for 7 days) via intraperitoneal injection in IBS rats caused an upregulation of AQP1, AQP3, AQP8, and inflammatory cytokines by AMP activation. The gene discussed is AQP1; the disease is irritable bowel syndrome.